TY - THES A1 - Biswas, Kajal T1 - Analysis of Nitrogen starvation induced filamentous growth and characterization of putative essential genes in the human fungal pathogen, Candida albicans N2 - 1. Zusammenfassung Candida albicans ist ein opportunistisch pathogener Hefepilz, der sowohl oberflächliche Infektionen der Schleimhaut als auch lebensbedrohliche systemische Infektionen hervorrufen kann. Obwohl die Fähigkeit von C.albicans Infektionen auszulösen weitgehend vom Immunstatus des Wirts abhängt, besitzt der Pilz doch auch spezifische Eigenschaften, die eine Kolonisierung, Disseminierung und Anpassung an unterschiedliche Wirtsnischen ermöglichen und ihn vom harmlosen Kommensalen zum gefährlichen Krankheitsserreger werden lassen. Unter bestimmten Umweltbedingungen geht C.albicans vom Wachstum als sprossende Hefe zum invasiven, filamentösen Wachstum über, das eine wichtige Rolle in der Pathogenität des Pilzes spielt. Stickstoffmangel ist eines der Signale, die das filamentöse Wachstum in C.albicans induzieren, und die Kontrolle der Morphogenese durch die Verfügbarkeit von Stickstoff wurde in dieser Arbeit detailliert untersucht. Ammonium ist für Hefepilze eine bevorzugte Stickstoffquelle, die über spezifische Transporter in die Zelle aufgenommen wird. In der vorliegenden Arbeit konnte gezeigt werden, dass C.albicans zwei Ammoniumpermeasen besitzt, deren Expression durch Stickstoffmangel induziert wird. Während die Deletion von CaMEP1 oder CaMEP2 keinen Einfluss auf das Wachstum bei limitierenden Ammoniumkonzentrationen hatte, konnten mep1 mep2 Doppelmutanten bei Ammoniumkonzentrationen unter 5 mM nicht mehr wachsen. Im Gegensatz zu mep1 Mutanten bildeten mep2 Mutanten unter Stickstoffmangel keine Hyphen mehr und wuchsen ausschließlich in der Hefeform. CaMep2p hat also nicht nur eine Funktion als Ammoniumtransporter, sondern spielt auch eine Rolle bei der Induktion des filamentösen Wachstums. Weitere Experimente zeigten, dass CaMep2p ein weniger effizienter Ammoniumtransporter als CaMep1p ist, dafür aber stärker exprimiert wird, und dass dieser Unterschied wichtig für die Signalfunktion von CaMep2p ist. Durch Deletionsanalysen konnte bewiesen werden, dass die C-terminale, cytoplasmatische Domäne von CaMep2p essentiell für die Induktion des Hyphenwachstums ist, für den Ammoniumtransport jedoch nicht benötigt wird, und diese beiden Funktionen von CaMep2p daher voneinander getrennt werden können. In C.albicans gibt es mindestens zwei Signalwege die das filamentöse Wachstum steuern, eine MAP-Kinase-Kaskade und einen cAMP-abhängigen Signalweg, die in den Transkriptionsfaktoren Cph1p bzw. Efg1p enden. Bei Inaktivierung des einen oder des anderen Signalwegs induziert Stickstoffmangel kein filamentöses Wachstum mehr. Ein hyperaktives CaMEP2 Allel konnte den filamentösen Wachstumsdefekt sowohl von cph1 als auch efg1 Mutanten aufheben, nicht jedoch den einer cph1 efg1 Doppelmutante oder einer Mutante, der das G-Protein Ras1p fehlte, das beide Signalwege aktiviert. Umgekehrt wurde der filamentöse Wachstumsdefekt von mep2 Mutanten durch ein dominant-aktives RAS1 Allel bzw. durch die Zugabe von cAMP aufgehoben. Diese Ergebnisse deuten darauf hin, dass CaMep2p bei Stickstoffmangel sowohl den MAP-Kinase- als auch den cAMP-abhängigen Signalweg aktiviert, um filamentöses Wachstum zu induzieren. In genügend hohen Konzentrationen reprimierte Ammonium das filamentöse Wachstum selbst wenn die Signalwege artifiziell aktiviert waren. Die bevorzugte Stickstoffquelle Ammonium ist deshalb ein Inhibitor der Morphogenese, der durch denselben Transporter in die Zelle aufgenommen wird, der bei Stickstoffmangel das filamentöse Wachstum von C.albicans induziert. Obwohl ein genaues Verständnis der Virulenzmechanismen von C.albicans auch neue Ansätze zur Bekämpfung von Infektionen durch diesen Pilz liefern kann, ist doch die Identifizierung und Charakterisierung von essentiellen Genen als potentielle Ziele für die Entwicklung neuer Antimykotika eine Strategie, die von der pharmazeutischen Industrie favorisiert wird. Aus diesem Grund wurden in Zusammenarbeit mit einem Industriepartner drei Gene von C.albicans ausgewählt, die in anderen Pilzen als essentiell beschrieben wurden, und im Rahmen dieser Arbeit funktionell charakterisiert. RAP1 codiert für das Repressor/Aktivator Protein 1, ein Transkriptionsfaktor und Telomerbindeprotein, das in der Bäckerhefe Saccharomyces cerevisiae essentiell ist. Die Deletion des RAP1 Gens in C.albicans beeinträchtigte jedoch nicht die Lebensfähigkeit der Mutanten, so dass RAP1 kein vielversprechendes Ziel darstellt. CBF1 (centromere binding factor 1) ist in S.cerevisiae wichtig für die korrekte Chromosomenverteilung während der Mitose und außerdem auch für die transkriptionelle Aktivierung der Methioninbiosynthesegene; in den verwandten Hefen Kluyveromyces lactis und Candida glabrata ist CBF1 sogar essentiell. C.albicans cbf1 Mutanten wiesen jedoch keinen erhöhten Chromosomenverlust auf, so dass CBF1 hier offensichtlich keine Rolle bei der Chromosomensegregation spielt. Allerdings waren die Mutanten auxotroph für schwefelhaltige Aminosäuren und generell stark im Wachstum beeinträchtigt, was zeigte, dass Cbf1p für das normale Wachstum von C.albicans wichtig ist. YIL19 ist in S.cerevisiae ein essentielles Gen und hat eine Funktion bei der Reifung der 18S rRNA. YIL19 stellte sich auch in C.albicans als essentiell heraus. Konditionale Mutanten, in denen YIL19 durch induzierbare, FLP-vermittelte Rekombination aus dem Genom deletiert wurde, waren nicht lebensfähig und akkumulierten rRNA Vorstufen. Durch diese Untersuchungen konnte gezeigt werden, dass YIL19 essentiell für diesen wichtigen zellulären Prozess und für die Lebensfähigkeit von C.albicans ist und sich möglicherweise als Ziel für die Entwicklung antifungaler Substanzen eignet. N2 - 1. Summary Candida albicans is an opportunistic human fungal pathogen that causes a variety of infections, ranging from superficial mucosal to deep-seated systemic infections, especially in immunocompromised patients. Although the ability of C.albicans to cause disease largely depends on the immune status of the host, the fungus also exhibits specific characteristics that facilitate colonization, dissemination, and adaptation to different host niches and thereby turn C.albicans from a harmless commensal to an aggressive pathogen. In response to various environmental stimuli C.albicans switches from growth as a budding yeast to invasive filamentous growth, and this morphogenetic switch plays an important role in C.albicans pathogenesis. Nitrogen limitation is one of the signals that induce filamentous growth in C.albicans, and the control of the morphogenetic transition by nitrogen availability was studied in detail in the present work. Ammonium is a preferred nitrogen source for yeasts that is taken up into the cells by specific transporters. It was found in this study that C.albicans possesses two major ammonium transporters, encoded by the CaMEP1 and CaMEP2 genes, expression of which is induced by nitrogen starvation. Whereas mep1 or mep2 single mutants grew as well as the wild-type strain on limiting concentrations of ammonium, deletion of both transporters rendered C.albicans unable to grow at ammonium concentrations below 5 mM. In contrast to mep1 mutants, mep2 mutants failed to filament and grew only in the yeast form under nitrogen starvation conditions, indicating that in addition to its role as an ammonium transporter CaMep2p also has a signaling function in the induction of filamentous growth. CaMep2p was found to be a less efficient ammonium transporter than CaMep1p and to be expressed at much higher levels, a distinguishing feature important for its signaling function. By the construction and analysis of serially truncated versions of CaMep2p, the C-terminal cytoplasmic tail of the protein was shown to be essential for signaling but dispensable for ammonium transport, demonstrating that these two functions of CaMep2p are separable. In C.albicans at least two signal transduction pathways, a MAP kinase cascade and a cAMP-dependent pathway ending in the transcriptional regulators Cph1p and Efg1p, respectively, control filamentous growth, and mutants defective in either one of these pathways are defective for filamentation under nitrogen starvation conditions. A hyperactive CaMEP2 allele rescued the filamentation defect of a cph1 or a efg1 mutant, but not of a cph1 efg1 double mutant or a mutant deleted for RAS1, which acts upstream of and activates both signaling pathways. Conversely, a dominant active RAS1 allele or addition of exogenous cAMP rescued the filamentation defect of mep2 mutants. These results suggest that CaMep2p activates both the MAP kinase and the cAMP pathway in a Ras1p dependent manner to promote filamentous growth under nitrogen starvation conditions. At sufficiently high concentrations, ammonium repressed filamentous growth even when the signaling pathways were artificially activated. Therefore, C.albicans has established a regulatory circuit in which a preferred nitrogen source, ammonium, serves as an inhibitor of morphogenesis that is taken up into the cell by the same transporter that induces filamentous growth in response to nitrogen starvation. Although a detailed understanding of virulence mechanisms of C.albicans may ultimately lead to novel approaches to combat infections caused by this pathogen, the identification and characterization of essential genes as potential targets for the development of antifungal drugs is a strategy favoured by most pharmaceutical companies. Therefore, C.albicans homologs of three genes that are essential in other fungi were selected in collaboration with an industrial partner and functionally characterized in this work. RAP1 encodes the repressor/activator protein 1, a transcription factor and telomere binding protein that is essential for viability in the budding yeast Saccharomyces cerevisiae. However, deletion of the C.albicans RAP1 homolog did not affect viability or growth of the mutants, suggesting that it is not a promising target. CBF1 (centromere binding factor 1) is necessary for proper chromosome segregation and transcriptional activation of methionine biosynthesis genes in S.cerevisiae and is essential for viability in the related yeasts Kluyveromyces lactis and Candida glabrata. Deletion of CBF1 in C.albicans did not result in an increased frequency of chromosome loss, indicating that it has no role in chromosome segregation in this organism. However, the C.albicans cbf1 mutants exhibited severe growth impairment, temperature sensitivity at 42°C, and auxotrophy for sulphur amino acids, suggesting that Cbf1p is a transcription factor that is important for normal growth of C.albicans. YIL19 is an essential gene in S.cerevisiae that is involved in 18S rRNA maturation. YIL19 was found to be an essential gene also in C.albicans. Conditional mutants in which the YIL19 gene could be excised from the genome by inducible, FLP-mediated recombination were non-viable and accumulated rRNA precursors, demonstrating that YIL19 is essential for this important cellular process and for viability of C.albicans and could serve as a target for the development of antifungal drugs. KW - Candida albicans KW - Pathogenität KW - Stickstoff KW - Candida albicans KW - ammonium permease KW - nitrogen regulation KW - essential gene Y1 - 2005 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-11554 ER - TY - JOUR A1 - Sasse, Christoph A1 - Schillig, Rebecca A1 - Dierolf, Franziska A1 - Weyler, Michael A1 - Schneider, Sabrina A1 - Mogavero, Selene A1 - Rogers, David P. A1 - Morschhäuser, Joachim T1 - The Transcription Factor Ndt80 Does Not Contribute to Mrr1-, Tac1-, and Upc2-Mediated Fluconazole Resistance in Candida albicans N2 - The pathogenic yeast Candida albicans can develop resistance to the widely used antifungal agent fluconazole, which inhibits ergosterol biosynthesis, by the overexpression of genes encoding multidrug efflux pumps or ergosterol biosynthesis enzymes. Zinc cluster transcription factors play a central role in the transcriptional regulation of drug resistance. Mrr1 regulates the expression of the major facilitator MDR1, Tac1 controls the expression of the ABC transporters CDR1 and CDR2, and Upc2 regulates ergosterol biosynthesis (ERG) genes. Gain-of-function mutations in these transcription factors result in constitutive overexpression of their target genes and are responsible for fluconazole resistance in many clinical C. albicans isolates. The transcription factor Ndt80 contributes to the drug-induced upregulation of CDR1 and ERG genes and also binds to the MDR1 and CDR2 promoters, suggesting that it is an important component of all major transcriptional mechanisms of fluconazole resistance. However, we found that Ndt80 is not required for the induction of MDR1 and CDR2 expression by inducing chemicals. CDR2 was even partially derepressed in ndt80D mutants, indicating that Ndt80 is a repressor of CDR2 expression. Hyperactive forms of Mrr1, Tac1, and Upc2 promoted overexpression of MDR1, CDR1/CDR2, and ERG11, respectively, with the same efficiency in the presence and absence of Ndt80. Mrr1- and Tac1-mediated fluconazole resistance was even slightly enhanced in ndt80D mutants compared to wild-type cells. These results demonstrate that Ndt80 is dispensable for the constitutive overexpression of Mrr1, Tac1, and Upc2 target genes and the increased fluconazole resistance of strains that have acquired activating mutations in these transcription factors. KW - Candida albicans Y1 - 2011 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-69201 ER - TY - THES A1 - Dunkel, Nico T1 - Regulation of virulence-associated traits of the human fungal pathogen Candida albicans by nitrogen availability T1 - Regulation Virulenz-assoziierter Faktoren im humanpathogenen Pilz Candida albicans durch Stickstoffverfügbarkeit N2 - Nitrogen-regulated pathogenesis describes the expression of virulence attributes as direct response to the quantity and quality of an available nitrogen source. As consequence of nitrogen availability, the opportunistic human fungal pathogen Candida albicans changes its morphology and secretes aspartic proteases [SAPs], both well characterized virulence attributes. C. albicans, contrarily to its normally non-pathogenic relative Saccharomyces cerevisiae, is able to utilize proteins, which are considered as abundant and important nitrogen source within the human host. To assimilate complex proteinaceous matter, extracellular proteolysis is followed by uptake of the degradation products through dedicated peptide transporters (di-/tripeptide transporters [PTRs] and oligopeptide transporters [OPTs]). The expression of both traits is transcriptionally controlled by Stp1 - the global regulator of protein utilization - in C. albicans. The aim of the present study was to elucidate the regulation of virulence attributes of the pathogenic fungus C. albicans by nitrogen availability in more detail. Within a genome wide binding profile of Stp1, during growth with proteins, more than 600 Stp1 target genes were identified, thereby confirming its role in the usage of proteins, but also other nitrogenous compounds as nitrogen source. Moreover, the revealed targets suggest an involvement of Stp1 in the general adaption to nutrient availability as well as in the environmental stress response. With the focus on protein utilization and nitrogen-regulated pathogenesis, the regulation of the major secreted aspartic protease Sap2 - additionally one of the prime examples of allelic heterogeneity in C. albicans - was investigated in detail. Thereby, the heterogezygous SAP2 promoter helped to identify an unintended genomic alteration as the true cause of a growth defect of a C. albicans mutant. Additionally, the promoter region, which was responsible for the differential activation of the SAP2 alleles, was delimited. Furthermore, general Sap2 induction was demonstrated to be mediated by distinct cis-acting elements that are required for a high or a low activity of SAP2 expression. For the utilization of proteins as nitrogen source it is also crucial to take up the peptides that are produced by extracellular proteolysis. Therefore, the function and importance of specific peptide transporters was investigated in C. albicans mutants, unable to use peptides as nitrogen source (opt1Δ/Δ opt2Δ/Δ opt3Δ/Δ opt4Δ/Δ opt5Δ/Δ ptr2Δ/Δ ptr22Δ/Δ septuple null mutants). The overexpression of individual transporters in these mutants revealed differential substrate specificities and expanded the specificity of the OPTs to dipeptides, a completely new facet of these transporters. The peptide-uptake deficient mutants were further used to elucidate, whether indeed proteins and peptides are an important in vivo nitrogen source for C. albicans. It was found that during competitive colonization of the mouse intestine these mutants exhibited wild-type fitness, indicating that neither proteins nor peptides are primary nitrogen sources required to efficiently support growth of C. albicans in the mouse gut. Adequate availability of the preferred nitrogen source ammonium represses the utilization of proteins and other alternative nitrogen sources, but also the expression of virulence attributes, like Sap secretion and nitrogen-starvation induced filamentation. In order to discriminate, whether ammonium availability is externally sensed or determined inside the cell by C. albicans, the response to exterior ammonium concentrations of ammonium-uptake deficient mutants (mep1Δ/Δ mep2Δ/Δ null mutants) was investigated. This study showed that presence of an otherwise suppressing ammonium concentration did not inhibit Sap2 proteases secretion and arginine-induced filamentation in these mutants. Conclusively, ammonium availability is primarily determined inside the cell in order to control the expression of virulence traits. In sum, the present work contributes to the current understanding of how C. albicans regulates expression of virulence-associated traits in response to the presence of available nitrogen sources - especially proteins and peptides - in order to adapt its lifestyle within a human host. N2 - Stickstoffregulierte Pathogenität bezeichnet die Kontrolle von Virulenz-assoziierten Eigenschaften als direkte Folge der verfügbaren Quantität und Qualität einer Stickstoffquelle. Im Zusammenhang mit der Stickstoffverfügbarkeit verändert der opportunistisch krankheitserregende Pilz Candida albicans seine Morphologie und sekretiert Aspartat-Proteasen [SAPs], beides gut charakterisierte Virulenzattribute. Im Gegensatz zu seinem normalerweise apathogenen Verwandten Saccharomyces cerevisiae ist C. albicans in der Lage Proteine zu verwerten, welche als sehr häufige und wichtige Stickstoffquelle im menschlichen Wirt angesehen werden. Zur Nutzung von Proteinen sekretiert C. albicans Aspartat-Proteasen für den außerzellulären Verdau der Proteine und exprimiert Peptidtransporter (Di- /Tripeptidtransporter [PTRs] und Oligopeptidtransporter [OPTs]) um die Abbauprodukte aufzunehmen. Beide Eigenschaften werden transkriptionell von Stp1 - dem globalen Regulator zur Verwertung von Proteinen - kontrolliert. Ziel der vorliegenden Arbeit war es, die Regulation von Virulenzattributen im pathogenen Pilz C. albicans durch die Verfügbarkeit von Stickstoff genauer zu untersuchen. Innerhalb einer genomweiten Bindestudie von Stp1 wurden mehr als 600 Stp1-Zielgene während des Wachstums mit Proteinen identifiziert. Dadurch bestätigte sich die Funktion von Stp1 in der Proteinverwertung und wurde zudem auch auf die allgemeine Verwertung von Stickstoffquellen erweitert. Des Weiteren deuten die aufgedeckten Zielgene an, dass Stp1 womöglich in der Adaption an die generelle Nährstoffverfügbarkeit sowie in der Antwort auf Stresssignale beteiligt ist. Mit dem Fokus auf die Proteinverwertung und stickstoffregulierter Pathogenität wurde die Regulation der wichtigsten sekretierten Protease Sap2 - welche außerdem ein Paradebeispiel für allelische Heterogenität ist - im Detail untersucht. Dabei half der heterogene SAP2-Promoter bei der Identifizierung einer unbeabsichtigten genomischen Veränderung als wahren Grund eines Wachstumsdefektes einer C. albicans Mutante. Zusätzlich wurde der Promotorbereich eingegrenzt, welcher für die unterschiedliche Aktivierung der beiden SAP2 Allele verantwortlich ist. Weiterhin wurden verschiedene cis-aktive Elemente identifiziert, die entweder für eine hohe oder eine niedrige SAP2 Expression benötigt werden. Die Aufnahme von Peptiden, die durch den außerzellulären Verdau entstehen, ist für die Verwertung von Proteinen ebenso wichtig. Deshalb wurde die Funktion und Bedeutung der spezifischen Peptidtransporter anhand von C. albicans Mutanten untersucht, welche Peptide nicht aufnehmen können (opt1Δ/Δ opt2Δ/Δ opt3Δ/Δ opt4Δ/Δ opt5Δ/Δ ptr2Δ/Δ ptr22Δ/Δ Septuplemutanten). Die Überexpression von individuellen Transportern in diesen Septuplemutanten offenbarte unterschiedliche Substratspezifitäten und erweiterte die Spezifität für die OPTs auf Dipeptide, eine komplett neue Facette dieser Transporter. Des Weiteren ermöglichten die Septuplemutanten eine Aufklärung, ob Proteine und Peptide tatsächlich eine wichtige In Vivo Stickstoffquelle für C. albicans sind. Dieses Arbeit zeigte, dass während der kompetitiven Kolonisierung des Mäusedarms die Septuplemutanten wildtypische Fitness aufwiesen. Dies deutet daraufhin, dass weder Proteine noch Peptide eine wichtige Stickstoffquelle für ein effizientes Wachstum in diesem In Vivo Model sind. Die ausreichende Verfügbarkeit der bevorzugten Stickstoffquelle Ammonium unterdrückt die Verwertung von Proteinen und anderen alternativen Stickstoffquellen. Aber auch die Expression von Virulenzattributen, wie die Proteasesekretion und die stickstoffmangel-induzierte Filamentierung, wird durch Ammonium inhibiert. Um zu unterscheiden, ob C. albicans die Ammoniumverfügbarkeit außerzellulär oder in der Zelle bestimmt, wurde das Verhalten auf außerzelluläre Ammoniumkonzentrationen in Mutanten untersucht, welche Ammonium nicht aufnehmen können (mep1Δ/Δ mep2Δ/Δ Mutanten). Diese Arbeit zeigte, dass in diesen Mutanten eine ansonsten inhibierende Ammoniumkonzentration nicht in der Lage war, die Sekretion der Sap2-Protease oder die Arginin-induzierte Hyphenbildung zu unterdrücken. Folglich wird, um die Expression von Virulenzattributen zu regulieren, die Ammoniumverfügbarkeit vorrangig in der Zelle bestimmt. Zusammenfassend erweitert die vorliegende Arbeit das Verständnis zur Regulation der Expression von Virulenzattributen durch die Verfügbarkeit von Stickstoffquellen - insbesondere Proteine und Peptide - die eine Anpassung von C. albicans an ein Leben im menschlichen Wirt ermöglichen. KW - Candida albicans KW - Regulation KW - Stickstoff KW - Virulenz KW - Proteasen KW - Nitrogen KW - SAP2 KW - STP1 KW - peptide KW - transport KW - ammonium KW - protease KW - Proteine Y1 - 2013 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-83076 ER - TY - JOUR A1 - Schielmann, Marta A1 - Szweda, Piotr A1 - Gucwa, Katarzyna A1 - Kawczyński, Marcin A1 - Milewska, Maria J. A1 - Martynow, Dorota A1 - Morschhäuser, Joachim A1 - Milewski, Sławomir T1 - Transport deficiency is the molecular basis of \(Candida\) \(albicans\) resistance to antifungal oligopeptides JF - Frontiers in Microbiology N2 - Oligopeptides incorporating \(N3\)-(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid (FMDP), an inhibitor of glucosamine-6-phosphate synthase, exhibited growth inhibitory activity against \(Candida\) \(albicans\), with minimal inhibitory concentration values in the 0.05–50 μg mL\(^{-1}\) range. Uptake by the peptide permeases was found to be the main factor limiting an anticandidal activity of these compounds. Di- and tripeptide containing FMDP (F2 and F3) were transported by Ptr2p/Ptr22p peptide transporters (PTR) and FMDP-containing hexa-, hepta-, and undecapeptide (F6, F7, and F11) were taken up by the oligopeptide transporters (OPT) oligopeptide permeases, preferably by Opt2p/Opt3p. A phenotypic, apparent resistance of \(C. albicans\) to FMDP-oligopeptides transported by OPT permeases was triggered by the environmental factors, whereas resistance to those taken up by the PTR system had a genetic basis. Anticandidal activity of longer FMDP-oligopeptides was strongly diminished in minimal media containing easily assimilated ammonium sulfate or L-glutamine as the nitrogen source, both known to downregulate expression of the OPT genes. All FMDP-oligopeptides tested were more active at lower pH and this effect was slightly more remarkable for peptides F6, F7, and F11, compared to F2 and F3. Formation of isolated colonies was observed inside the growth inhibitory zones induced by F2 and F3 but not inside those induced by F6, F7, and F11. The vast majority (98%) of those colonies did not originate from truly resistant cells. The true resistance of 2% of isolates was due to the impaired transport of di- and to a lower extent, tripeptides. The resistant cells did not exhibit a lower expression of \(PTR2\), \(PTR22\), or \(OPT1–3\) genes, but mutations in the \(PTR2\) gene resulting in T422H, A320S, D119V, and A320S substitutions in the amino acid sequence of Ptr2p were found. KW - microbiology KW - Candida albicans KW - oligopeptides KW - resistance mechanism KW - permease KW - antifungals Y1 - 2017 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-173245 VL - 8 ER - TY - JOUR A1 - Böhm, Lena A1 - Torsin, Sanda A1 - Tint, Su Hlaing A1 - Eckstein, Marie Therese A1 - Ludwig, Tobias A1 - Pérez, J. Christian T1 - The yeast form of the fungus Candida albicans promotes persistence in the gut of gnotobiotic mice JF - PLoS Pathogens N2 - Many microorganisms that cause systemic, life-threatening infections in humans reside as harmless commensals in our digestive tract. Yet little is known about the biology of these microbes in the gut. Here, we visualize the interface between the human commensal and pathogenic fungus Candida albicans and the intestine of mice, a surrogate host. Because the indigenous mouse microbiota restricts C. albicans settlement, we compared the patterns of colonization in the gut of germ free and antibiotic-treated conventionally raised mice. In contrast to the heterogeneous morphologies found in the latter, we establish that in germ free animals the fungus almost uniformly adopts the yeast cell form, a proxy of its commensal state. By screening a collection of C. albicans transcription regulator deletion mutants in gnotobiotic mice, we identify several genes previously unknown to contribute to in vivo fitness. We investigate three of these regulators—ZCF8, ZFU2 and TRY4—and show that indeed they favor the yeast form over other morphologies. Consistent with this finding, we demonstrate that genetically inducing non-yeast cell morphologies is detrimental to the fitness of C. albicans in the gut. Furthermore, the identified regulators promote adherence of the fungus to a surface covered with mucin and to mucus-producing intestinal epithelial cells. In agreement with this result, histology sections indicate that C. albicans dwells in the murine gut in close proximity to the mucus layer. Thus, our findings reveal a set of regulators that endows C. albicans with the ability to endure in the intestine through multiple mechanisms. KW - Candida albicans KW - deletion mutagenesis KW - gastrointestinal tract KW - fungi KW - regulator genes KW - gene regulation KW - mouse models KW - fungal genetics Y1 - 2017 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-159120 VL - 13 IS - 10 ER - TY - JOUR A1 - Hampe, Irene A. I. A1 - Friedman, Justin A1 - Edgerton, Mira A1 - Morschhäuser, Joachim T1 - An acquired mechanism of antifungal drug resistance simultaneously enables Candida albicans to escape from intrinsic host defenses JF - PLoS Pathogens N2 - The opportunistic fungal pathogen Candida albicans frequently produces genetically altered variants to adapt to environmental changes and new host niches in the course of its life-long association with the human host. Gain-of-function mutations in zinc cluster transcription factors, which result in the constitutive upregulation of their target genes, are a common cause of acquired resistance to the widely used antifungal drug fluconazole, especially during long-term therapy of oropharyngeal candidiasis. In this study, we investigated if C. albicans also can develop resistance to the antimicrobial peptide histatin 5, which is secreted in the saliva of humans to protect the oral mucosa from pathogenic microbes. As histatin 5 has been shown to be transported out of C. albicans cells by the Flu1 efflux pump, we screened a library of C. albicans strains that contain artificially activated forms of all zinc cluster transcription factors of this fungus for increased FLU1 expression. We found that a hyperactive Mrr1, which confers fluconazole resistance by upregulating the multidrug efflux pump MDR1 and other genes, also causes FLU1 overexpression. Similarly to the artificially activated Mrr1, naturally occurring gain-of-function mutations in this transcription factor also caused FLU1 upregulation and increased histatin 5 resistance. Surprisingly, however, Mrr1-mediated histatin 5 resistance was mainly caused by the upregulation of MDR1 instead of FLU1, revealing a previously unrecognized function of the Mdr1 efflux pump. Fluconazole-resistant clinical C. albicans isolates with different Mrr1 gain-of-function mutations were less efficiently killed by histatin 5, and this phenotype was reverted when MRR1 was deleted. Therefore, antimycotic therapy can promote the evolution of strains that, as a consequence of drug resistance mutations, simultaneously have acquired increased resistance against an innate host defense mechanism and are thereby better adapted to certain host niches. KW - antimicrobial resistance KW - transcriptional control KW - Candida albicans KW - transcription factors KW - mutation KW - hyperexpression techniques KW - antifungals KW - point mutation Y1 - 2017 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-158883 VL - 13 IS - 9 ER - TY - THES A1 - Hampe, Irene Aurelia Ida T1 - Analysis of the mechanism and the regulation of histatin 5 resistance in \(Candida\) \(albicans\) T1 - Analyse des Mechanismus und der Regulierung von Histatin 5 Resistenz in \(Candida\) \(albicans\) N2 - Antimycotics such as fluconazole are frequently used to treat C. albicans infections of the oral mucosa. Prolonged treatment of the fungal infection with fluconazole pose a risk to resistance development. C. albicans can adapt to these stressful environmental changes by regulation of gene expression or by producing genetically altered variants that arise in the population. Adapted variants frequently carry activating mutations in zinc cluster transcription factors, which cause the upregulation of their target genes, including genes encoding efflux pumps that confer drug resistance. MDR1, regulated by the zinc cluster transcription factor Mrr1, as well as CDR1 and CDR2, regulated by the zinc cluster transcription factor Tac1, are well-known examples of genes encoding efflux pumps that extrude the antimycotic fluconazole from the fungal cell and thus contribute to the survival of the fungus. In this study, it was investigated if C. albicans can develop resistance to the antimicrobial peptide histatin 5, which serves as the first line of defence in the oral cavity of the human host. Recently, it was shown that C. albicans transports histatin 5 outside of the Candia cell via the efflux pump Flu1. As efflux pumps are often regulated by zinc cluster transcription factors, the Flu1 efflux pump could also be regulated by a zinc cluster transcription factor which could in a hyperactive form upregulate the expression of the efflux pump, resulting in increased export of histatin 5 and consequently in histatin 5 resistance. In order to find a zinc cluster transcription factor that upregulates FLU1 expression, a comprehensive library of C. albicans strains containing artificially activated forms of zinc cluster transcription factors was screened for suitable candidates. The screening was conducted on medium containing mycophenolic acid because mycophenolic acid is also a substrate of Flu1 and a strain expressing a hyperactive zinc cluster transcription factor that upregulates FLU1 expression should exhibit an easily recognisable mycophenolic acid-resistant phenotype. Further, FACS analysis, quantitative real-time RT-PCR analysis, broth microdilution assays as well as histatin 5 assays were conducted to analyse the mechanism and the regulation of histatin 5 resistance. Several zinc cluster transcription factors caused mycophenolic acid resistance and upregulated FLU1 expression. Of those, only hyperactive Mrr1 was able to confer increased histatin 5 resistance. Finding Mrr1 to confer histatin 5 resistance was highly interesting as fluconazole-resistant strains with naturally occurring Mrr1 gain of function mutations exist, which were isolated from HIV-infected patients with oral candidiasis. These Mrr1 gain of function mutations as well as artificially activated Mrr1 cause fluconazole resistance by upregulation of the efflux pump MDR1 and other target genes. In the course of the study, it was found that expression of different naturally occurring MRR1 gain-of-function mutations in the SC5314 wild type background caused increased FLU1 expression and increased histatin 5 resistance. The same was true for fluconazole-resistant clinical isolates with Mrr1 gain of function mutations, which also caused the overexpression of FLU1. Those cells were less efficiently killed by histatin 5 dependent on Mrr1. Surprisingly, FLU1 contributed only little to histatin 5 resistance, rather, overexpression of MDR1 mainly contributed to the Mrr1-mediated histatin 5 resistance, but also additional Mrr1-target genes were involved. These target genes are yet to be uncovered. Moreover, if a link between the yet unknown Mrr1-target genes contributing to fluconazole resistance and increased histatin 5 resistance can be drawn remains to be discovered upon finding of the responsible target genes. Collectively, this study contributes to the understanding of the impact of prolonged antifungal exposure on the interaction between host and fungus. Drug therapy can give rise to resistance evolution resulting in strains that have not only developed resistance to fluconazole but also to an innate host mechanism, which allows adaption to the host niche even in the absence of the drug. N2 - Antimykotika wie Fluconazol werden häufig zur Behandlung von C. albicans Infektionen der Mundschleimhaut verwendet. Dabei stellt eine langzeitige Behandlung der Pilzinfektion mit Fluconazol ein Risiko zur Resistenzentwicklung dar. C. albicans kann sich an solche Umweltveränderungen anpassen, indem es die Genexpression reguliert oder genetisch veränderte Varianten produziert, welche in der Population entstehen. Adaptierte Varianten tragen häufig aktivierende Mutationen in Zink-Cluster-Transkriptionsfaktoren, welche die Hochregulierung der Expression von Genen verursachen, darunter solche, die für Multidrug-Effluxpumpen kodieren und dadurch Antimykotikaresistenz verleihen können. MDR1, reguliert durch den Zink-Cluster-Transkriptionsfaktor Mrr1, sowie CDR1 und CDR2, reguliert durch den Zink-Cluster-Transkriptionsfaktor Tac1, sind bekannte Beispiele für Effluxpumpen, die das Antimykotikum Fluconazol aus der Pilzzelle extrudieren und somit zum Überleben der Pilzzelle beitragen. In dieser Arbeit wurde untersucht, ob C. albicans eine Resistenz gegen das antimikrobielle Peptid Histatin 5 entwickeln kann, das in der Mundhöhle des menschlichen Wirtes als erste Verteidigungsbarriere gegen den Pilz dient. Kürzlich wurde gezeigt, dass C. albicans Histatin 5 über die Effluxpumpe Flu1 aus der Candia-Zelle heraustransportiert (Li et al., 2013). Da Effluxpumpen häufig durch Zink-Cluster-Transkriptionsfaktoren reguliert werden, könnte auch die Flu1-Effluxpumpe durch solch einen Transkriptionsfaktor reguliert werden, der in einer hyperaktiven Form die Expression der Effluxpumpe hochregulieren könnte, was wiederrum zu einem erhöhten Export von Histatin 5 und folglich zur Histatin 5 Resistenz führen könnte. Um einen Zink-Cluster-Transkriptionsfaktor zu finden, der die FLU1-Expression hochreguliert, wurde mit Hilfe einer Bibliothek von C. albicans-Stämmen, die künstlich aktivierte Formen von Zink-Cluster-Transkriptionsfaktoren enthält, nach geeigneten Kandidaten gesucht. Das Screening wurde auf Mycophenolsäure-haltigem Medium durchgeführt, da Mycophenolsäure ebenfalls ein Substrat von Flu1 ist. Folglich sollte ein Stamm mit hyperaktivem Zink-Cluster-Transkriptionsfaktor, welcher die FLU1-Expression hochreguliert, einen leicht erkennbaren Mycophenolsäure-resistenten Phänotyp aufweisen. Weiterhin wurden FACS-Analysen, quantitative real-time RT-PCR-Analysen, Broth microdilution-Assays sowie Histatin 5-Assays durchgeführt, um den Mechanismus und die Regulierung der Histatin-5-Resistenz zu analysieren. Mehrere Zink-Cluster-Transkriptionsfaktoren verursachten Mycophenolsäure-Resistenz und erhöhten die FLU1-Expression. Von diesen war nur hyperaktives Mrr1 in der Lage, eine erhöhte Histatin-5-Resistenz zu verleihen. Das Auffinden von Mrr1 als Regulator der Histatin 5-Resistenz war hochinteressant, da fluconazolresistente Stämme mit natürlich vorkommenden MRR1 gain-of-function Mutationen existieren, die aus HIV-infizierten Patienten mit oropharyngealer Candidiasis isoliert wurden. Diese gain-of-function Mutationen sowie künstlich aktivierendes Mrr1 verursachen Fluconazol-Resistenz durch Hochregulation der Effluxpumpe MDR1 und anderer Zielgene. Im Verlauf der Studie wurde herausgefunden, dass verschiedene natürlich vorkommende MRR1 gain-of-function Mutationen im SC5314 Wildtyp Hintergrund eine erhöhte FLU1-Expression und eine erhöhte Histatin-5-Resistenz verursachten. Das Gleiche galt für Fluconazol-resistente klinische Isolate mit Mrr1 gain-of-function Mutationen, welche die Überexpression von FLU1 verursachten. Zellen dieser Isolate wurden, abhängig von Mrr1, weniger wirksam durch Histatin 5 abgetötet. Überraschenderweise trug FLU1 nur wenig zur Histatin-5-Resistenz bei, vielmehr trug die Überexpression von MDR1 hauptsächlich zur Mrr1-vermittelten Histatin-5-Resistenz bei, aber auch weitere Mrr1-Zielgene waren daran beteiligt. Diese Mrr1-Zielgene gilt es nun noch zu entdecken. Ob ein Zusammenhang zwischen diesen noch unbekannten Mrr1-Zielgenen hergestellt werden kann, die zur Fluconazolresistenz sowie zu einer erhöhten Histatin-5-Resistenz beitragen, wird erst nach dem Auffinden der verantwortlichen Zielgene geprüft werden können. Zusammenfassend trägt diese Studie zum Verständnis der Auswirkungen einer anhaltenden antimykotischen Exposition auf die Interaktion zwischen Wirt und Pilz bei. Eine medikamentöse Therapie kann zu einer Resistenzentwicklung führen, aus der Stämme hervorgehen, welche nicht nur eine Resistenz gegen Fluconazol entwickelt haben, sondern gleichzeitig eine Resistenz gegen einen angeborenen Wirtsabwehrmechanismus, der eine Adaption an die Wirtsnische auch in Abwesenheit des Antimykotikums ermöglicht. KW - Histatin 5 KW - Candida albicans KW - Efflux pump KW - MDR1 KW - MRR1 KW - Mrr1 KW - MDR1 KW - Fluconazole KW - Efflux pump Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-159634 ER - TY - JOUR A1 - Popp, Christina A1 - Ramírez-Zavala, Bernardo A1 - Schwanfelder, Sonja A1 - Krüger, Ines A1 - Morschhäuser, Joachim T1 - Evolution of fluconazole-resistant Candida albicans strains by drug-induced mating competence and parasexual recombination JF - mBio N2 - The clonal population structure of Candida albicans suggests that (para)sexual recombination does not play an important role in the lifestyle of this opportunistic fungal pathogen, an assumption that is strengthened by the fact that most C. albicans strains are heterozygous at the mating type locus (MTL) and therefore mating-incompetent. On the other hand, mating might occur within clonal populations and allow the combination of advantageous traits that were acquired by individual cells to adapt to adverse conditions. We have investigated if parasexual recombination may be involved in the evolution of highly drug-resistant strains exhibiting multiple resistance mechanisms against fluconazole, an antifungal drug that is commonly used to treat infections by C. albicans. Growth of strains that were heterozygous for MTL and different fluconazole resistance mutations in the presence of the drug resulted in the emergence of derivatives that had become homozygous for the mutated allele and the mating type locus and exhibited increased drug resistance. When MTLa/a and MTLα/α cells of these strains were mixed in all possible combinations, we could isolate mating products containing the genetic material from both parents. The initial mating products did not exhibit higher drug resistance than their parental strains, but further propagation under selective pressure resulted in the loss of the wild-type alleles and increased fluconazole resistance. Therefore, fluconazole treatment not only selects for resistance mutations but also promotes genomic alterations that confer mating competence, which allows cells in an originally clonal population to exchange individually acquired resistance mechanisms and generate highly drug-resistant progeny. KW - Candida albicans KW - drug resistance evolution KW - mating KW - parasexual recombination Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-200901 VL - 10 IS - 1 ER - TY - JOUR A1 - Mottola, Austin A1 - Morschhäuser, Joachim T1 - An intragenic recombination event generates a Snf4-independent form of the essential protein kinase SNF1 in Candida albicans JF - mSphere N2 - The heterotrimeric protein kinase SNF1 plays a key role in the metabolic adaptation of the pathogenic yeast Candida albicans. It consists of the essential catalytic α-subunit Snf1, the γ-subunit Snf4, and one of the two β-subunits Kis1 and Kis2. Snf4 is required to release the N-terminal catalytic domain of Snf1 from autoinhibition by the C-terminal regulatory domain, and snf4Δ mutants cannot grow on carbon sources other than glucose. In a screen for suppressor mutations that restore growth of a snf4Δ mutant on alternative carbon sources, we isolated a mutant in which six amino acids between the N-terminal kinase domain and the C-terminal regulatory domain of Snf1 were deleted. The deletion was caused by an intragenic recombination event between two 8-bp direct repeats flanking six intervening codons. In contrast to truncated forms of Snf1 that contain only the kinase domain, the Snf4-independent Snf1\(^{Δ311 − 316}\) was fully functional and could replace wild-type Snf1 for normal growth, because it retained the ability to interact with the Kis1 and Kis2 β-subunits via its C-terminal domain. Indeed, the Snf4-independent Snf1\(^{Δ311 − 316}\) still required the β-subunits of the SNF1 complex to perform its functions and did not rescue the growth defects of kis1Δ mutants. Our results demonstrate that a preprogrammed in-frame deletion event within the SNF1 coding region can generate a mutated form of this essential kinase which abolishes autoinhibition and thereby overcomes growth deficiencies caused by a defect in the γ-subunit Snf4. KW - AMP-activated kinases KW - Candida albicans KW - genetic recombination KW - metabolic adaptation KW - suppressor mutation Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-202170 VL - 4 IS - 3 ER - TY - JOUR A1 - Mottola, Austin A1 - Schwanfelder, Sonja A1 - Morschhäuser, Joachim T1 - Generation of Viable Candida albicans Mutants Lacking the "Essential" Protein Kinase Snf1 by Inducible Gene Deletion JF - mSphere N2 - The protein kinase Snf1, a member of the highly conserved AMP-activated protein kinase family, is a central regulator of metabolic adaptation. In the pathogenic yeast Candida albicans, Snf1 is considered to be essential, as previous attempts by different research groups to generate homozygous snf1 Delta mutants were unsuccessful. We aimed to elucidate why Snf1 is required for viability in C. albicans by generating snf1 Delta null mutants through forced, inducible gene deletion and observing the terminal phenotype before cell death. Unexpectedly, we found that snf1 Delta mutants were viable and could grow, albeit very slowly, on rich media containing the preferred carbon source glucose. Growth was improved when the cells were incubated at 37 degrees C instead of 30 degrees C, and this phenotype enabled us to isolate homozygous snf1 Delta mutants also by conventional, sequential deletion of both SNF1 alleles in a wild-type C. albicans strain. All snf1 Delta mutants could grow slowly on glucose but were unable to utilize alternative carbon sources. Our results show that, under optimal conditions, C. albicans can live and grow without Snf1. Furthermore, they demonstrate that inducible gene deletion is a powerful method for assessing gene essentiality in C. albicans. IMPORTANCE Essential genes are those that are indispensable for the viability and growth of an organism. Previous studies indicated that the protein kinase Snf1, a central regulator of metabolic adaptation, is essential in the pathogenic yeast Candida albicans, because no homozygous snf1 deletion mutants of C. albicans wild-type strains could be obtained by standard approaches. In order to investigate the lethal consequences of SNF1 deletion, we generated conditional mutants in which SNF1 could be deleted by forced, inducible excision from the genome. Unexpectedly, we found that snf1 null mutants were viable and could grow slowly under optimal conditions. The growth phenotypes of the snf1 Delta mutants explain why such mutants were not recovered in previous attempts. Our study demonstrates that inducible gene deletion is a powerful method for assessing gene essentiality in C. albicans. KW - Candida albicans KW - Snf1 KW - conditional mutants KW - essential genes KW - protein kinases Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-230524 VL - 5 IS - 4 ER - TY - THES A1 - Popp, Christina T1 - Evolution of antifungal drug resistance of the human-pathogenic fungus \(Candida\) \(albicans\) T1 - Evolution der Antimykotikaresistenz im humanpathogenen Pilz \(Candida\) \(albicans\) N2 - Infections with the opportunistic yeast Candida albicans are frequently treated with the first-line drug fluconazole, which inhibits ergosterol biosynthesis. An alarming problem in clinics is the development of resistances against this azole, especially during long-term treatment of patients. Well-known resistance mechanisms include mutations in the zinc cluster transcription factors (ZnTFs) Mrr1 and Tac1, which cause an overexpression of efflux pump genes, and Upc2, which results in an overexpression of the drug target. C. albicans strains with such gain-of-function mutations (GOF) have an increased drug resistance conferring a selective advantage in the presence of the drug. It was previously shown that this advantage comes with a fitness defect in the absence of the drug. This was observed in different conditions and is presumably caused by a deregulated gene expression. One aim of the present study was to examine whether C. albicans can overcome the costs of drug resistance by further evolution. Therefore, the relative fitness of clinical isolates with one or a combination of different resistance mutations in Mrr1, Tac1 and/or Upc2 was analyzed in competition with the matched fluconazole-susceptible partner. Most fluconazole-resistant isolates had a decreased fitness in competition with their susceptible partner in vitro in rich medium. In contrast, three fluconazole-resistant strains with Mrr1 resistance mutations did not show a fitness defect in competition with their susceptible partner. In addition, the fitness of four selected clinical isolate pairs was examined in vivo in mouse models of gastrointestinal colonization (GI) and disseminated infection (IV). In the GI model all four fluconazole-resistant strains were outcompeted by their respective susceptible partner. In contrast, in the IV model only one out of four fluconazole-resistant isolates did show a slight fitness defect in competition with its susceptible partner during infection of the kidneys. It can be stated, that in the present work the in vitro fitness did not reflect the in vivo fitness and that the overall fitness was dependent on the tested conditions. In conclusion, C. albicans cannot easily overcome the costs of drug resistance caused by a deregulated gene expression. In addition to GOFs in Mrr1, Tac1 and Upc2, resistance mutations in the drug target Erg11 are a further key fluconazole resistance mechanism of C. albicans. Clinical isolates often harbor several resistance mechanisms, as the fluconazole resistance level is further increased in strains with a combination of different resistance mutations. In this regard, the question arises of how strains with multiple resistance mechanisms evolve. One possibility is that strains acquire mutations successively. In the present study it was examined whether highly drug-resistant C. albicans strains with multiple resistance mechanisms can evolve by parasexual recombination as another possibility. In a clonal population, cells with individually acquired resistance mutations could combine these advantageous traits by mating. Thereupon selection could act on the mating progeny resulting in even better adapted derivatives. Therefore, strains heterozygous for a resistance mutation and the mating type locus (MTL) were grown in the presence of fluconazole. Derivatives were isolated, which had become homozygous for the resistance mutation and at the same time for the MTL. This loss of heterozygosity was accompanied by increased drug resistance. In general, strains which are homozygous for one of both MTL configurations (MTLa and MTLα) can switch to the opaque phenotype, which is the mating-competent form of the yeast, and mate with cells of the opposite MTL. In the following, MTLa and MTLα homozygous strains in the opaque phenotype were mated in all possible combinations. The resulting mating products with combined genetic material from both parents did not show an increased drug resistance. Selected products of each mating cross were passaged with stepwise increasing concentrations of fluconazole. The isolated progeny showed high levels of drug resistance and loss of wild-type alleles of resistance-associated genes. In conclusion, selective pressure caused by fluconazole exposure selects for resistance mutations and at the same time induces genomic rearrangements, resulting in mating competence. Therefore, in a clonal population, cells with individually acquired resistance mutations can mate with each other and generate mating products with combined genetic backgrounds. Selection can act on these mating products and highly drug-resistant und thus highly adapted derivatives can evolve as a result. In summary, the present study contributes to the current understanding of the evolution of antifungal drug resistance by elucidating the effect of resistance mutations on the fitness of the strains in the absence of the drug selection pressure and investigates how highly drug-resistant strains could evolve within a mammalian host. N2 - Infektionen mit dem opportunistischen Hefepilz Candida albicans werden häufig mit dem First-Line-Medikament Fluconazol behandelt, welches die Ergosterol-Biosynthese hemmt. Ein besorgniserregendes Problem in der Klinik, insbesondere bei der Langzeitbehandlung von Patienten, ist die Entwicklung von Resistenzen gegen dieses Azol. Zu den bekannten Resistenzmechanismen gehören Resistenzmutationen in den Zink-Cluster-Transkriptionsfaktoren (ZnTFs) Mrr1 und Tac1, die eine Überexpression von Effluxpumpen-Genen bewirken und Resistenzmutationen in Upc2, die zu einer Überexpression des Wirkstofftargets führen. C. albicans Stämme mit solchen Gain-of-Function-Mutationen (GOF) weisen eine erhöhte Medikamentenresistenz auf, was einen selektiven Vorteil in Gegenwart des Medikaments bedeutet. Es wurde zuvor gezeigt, dass dieser Vorteil mit einem Fitnessdefekt in Abwesenheit des Medikaments einhergeht. Dies wurde in verschiedenen Bedingungen nachgewiesen und wird vermutlich durch eine deregulierte Genexpression verursacht. Ein Ziel der vorliegenden Studie war es zu untersuchen, ob C. albicans die Kosten der Medikamentenresistenz durch Evolution kompensieren kann. Daher wurde die relative Fitness von klinischen Isolaten mit einer oder einer Kombination verschiedener Resistenzmutationen in Mrr1, Tac1 und/oder Upc2 im Wettbewerb mit dem zugehörigen Fluconazol-sensitiven Partner analysiert. Die meisten Fluconazol-resistenten Isolate hatten eine verminderte Fitness im Wettbewerb mit ihrem sensitiven Partner in vitro in vollwertigem Medium. Dennoch zeigten drei Fluconazol-resistente Stämme mit Mrr1-Resistenzmutationen keinen Fitnessdefekt im Wettbewerb mit ihrem jeweiligen Partner. Zusätzlich wurde die Fitness von vier ausgewählten klinischen Isolat-Paaren in vivo in Mausmodellen für gastrointestinale Kolonisation (GI) und disseminierte Infektion (IV) untersucht. Im GI-Modell wurden alle vier Fluconazol-resistenten Stämme von ihren sensitiven Partnern überwachsen. Im Gegensatz dazu zeigte im IV-Modell nur einer der vier Fluconazol-resistenten Isolate einen leichten Fitnessdefekt im Wettbewerb mit dem jeweiligen Fluconazol-sensitiven Partner während der Infektion der Nieren. Es kann festgestellt werden, dass in der vorliegenden Arbeit die in vitro-Fitness nicht die in vivo-Fitness widerspiegelt und dass die Gesamtfitness von den getesteten Bedingungen abhängig ist. Zusammenfassend lässt sich sagen, dass C. albicans die Kosten der Medikamentenresistenz, die durch eine deregulierte Genexpression verursacht werden, nur schwer überwinden kann. Neben GOFs in Mrr1, Tac1 und Upc2 sind Resistenzmutationen im Wirkstofftarget Erg11 ein wichtiger Resistenzmechanismus von C. albicans. Klinische Isolate weißen oft mehrere Resistenzmechanismen auf, da die Kombination verschiedener Resistenzmutationen die Fluconazol-Resistenz potenziert. In diesem Zusammenhang stellt sich die Frage, wie sich Stämme mit mehreren Resistenzmechanismen entwickeln. Eine Möglichkeit ist, dass Stämme Mutationen sequenziell erwerben. In der vorliegenden Studie wurde untersucht, ob als weitere Möglichkeit hochresistente C. albicans Stämme mit multiplen Resistenzmechanismen durch parasexuelle Rekombination evolvieren können. In einer klonalen Population könnten Zellen mit individuell erworbenen Resistenzmutationen diese vorteilhaften Eigenschaften durch Paarung kombinieren. Daraufhin könnte Selektionsdruck auf die Matingprodukte wirken und so die Entstehung von besser angepassten Derivaten begünstigen. Daher wurden Resistenzmutation und Mating Type Locus (MTL) heterozygote Stämme in Gegenwart von Fluconazol kultiviert. So konnten Derivate isoliert werden, die homozygot für die Resistenzmutation und gleichzeitig für den MTL geworden waren. Dieser Verlust der Heterozygotie ging mit einer erhöhten Medikamentenresistenz einher. Generell können Stämme, die homozygot für eine der beiden MTL-Konfigurationen (MTLa und MTLα) sind, in den opaque Phänotyp wechseln, der die paarungskompetente Form der Hefe darstellt, und sich mit Zellen des gegensätzlichen MTL paaren. Im Folgenden wurden MTLa und MTLα homozygote Stämme im opaque Phänotyp in allen möglichen Kombinationen verpaart. Die resultierenden Matingprodukte mit kombiniertem genetischem Material beider Elternteile wiesen keine erhöhte Medikamentenresistenz auf. Ausgewählte Paarungsprodukte jeder Kreuzung wurden mit stufenweise ansteigenden Konzentrationen von Fluconazol passagiert. Die isolierten Nachkommen zeigten ein hohes Maß an Medikamentenresistenz und den Verlust von Wildtyp-Allelen der resistenzassoziierten Gene. Zusammenfassend lässt sich sagen, dass der selektive Druck, der durch die Fluconazol-Exposition verursacht wird, für Resistenzmutationen selektiert und gleichzeitig genomische Umlagerungen induziert, die eine Paarung ermöglichen. Daher können sich in einer klonalen Population Zellen mit individuell erworbenen Resistenzmutationen miteinander paaren und Matingprodukte mit kombiniertem genetischem Hintergrund generieren. Auf diese Matingprodukte kann die Selektion wirken, woraufhin sich hochresistente und damit stark an ihre Umwelt angepasste Derivate entwickeln können. Zusammenfassend trägt die vorliegende Studie zum aktuellen Verständnis der Evolution der Antimykotika-Resistenz bei, indem sie den Effekt von Resistenzmutationen auf die Fitness der Stämme in Abwesenheit des Medikamenten-Selektionsdrucks untersucht und aufklärt, wie sich hochgradig resistente Stämme in einem Säugetierwirt entwickeln könnten. KW - Evolution KW - Resistenz KW - Fitness KW - Candida albicans KW - Fluconazol KW - Resistance KW - Fluconazole KW - Drug resistance KW - Human-pathogenic KW - Yeast Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-243515 ER - TY - JOUR A1 - Mottola, Austin A1 - Ramírez-Zavala, Bernardo A1 - Hünninger, Kerstin A1 - Kurzai, Oliver A1 - Morschhäuser, Joachim T1 - The zinc cluster transcription factor Czf1 regulates cell wall architecture and integrity in Candida albicans JF - Molecular Microbiology N2 - The fungal cell wall is essential for the maintenance of cellular integrity and mediates interactions of the cells with the environment. It is a highly flexible organelle whose composition and organization is modulated in response to changing growth conditions. In the pathogenic yeast Candida albicans, a network of signaling pathways regulates the structure of the cell wall, and mutants with defects in these pathways are hypersensitive to cell wall stress. By harnessing a library of genetically activated forms of all C. albicans zinc cluster transcription factors, we found that a hyperactive Czf1 rescued the hypersensitivity to cell wall stress of different protein kinase deletion mutants. The hyperactive Czf1 induced the expression of many genes with cell wall-related functions and caused visible changes in the cell wall structure. C. albicans czf1Δ mutants were hypersensitive to the antifungal drug caspofungin, which inhibits cell wall biosynthesis. The changes in cell wall architecture caused by hyperactivity or absence of Czf1 resulted in an increased recognition of C. albicans by human neutrophils. Our results show that Czf1, which is known as a regulator of filamentous growth and white-opaque switching, controls the expression of cell wall genes and modulates the architecture of the cell wall. KW - cell wall KW - zinc cluster transcription factor KW - Candida albicans KW - protein kinases Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-259583 VL - 116 IS - 2 ER - TY - JOUR A1 - Ramírez-Zavala, Bernardo A1 - Krüger, Ines A1 - Dunker, Christine A1 - Jacobsen, Ilse D. A1 - Morschhäuser, Joachim T1 - The protein kinase Ire1 has a Hac1-independent essential role in iron uptake and virulence of Candida albicans JF - PLoS Pathogens N2 - Protein kinases play central roles in virtually all signaling pathways that enable organisms to adapt to their environment. Microbial pathogens must cope with severely restricted iron availability in mammalian hosts to invade and establish themselves within infected tissues. To uncover protein kinase signaling pathways that are involved in the adaptation of the pathogenic yeast Candida albicans to iron limitation, we generated a comprehensive protein kinase deletion mutant library of a wild-type strain. Screening of this library revealed that the protein kinase Ire1, which has a conserved role in the response of eukaryotic cells to endoplasmic reticulum stress, is essential for growth of C. albicans under iron-limiting conditions. Ire1 was not necessary for the activity of the transcription factor Sef1, which regulates the response of the fungus to iron limitation, and Sef1 target genes that are induced by iron depletion were normally upregulated in ire1Δ mutants. Instead, Ire1 was required for proper localization of the high-affinity iron permease Ftr1 to the cell membrane. Intriguingly, iron limitation did not cause increased endoplasmic reticulum stress, and the transcription factor Hac1, which is activated by Ire1-mediated removal of the non-canonical intron in the HAC1 mRNA, was dispensable for Ftr1 localization to the cell membrane and growth under iron-limiting conditions. Nevertheless, expression of a pre-spliced HAC1 copy in ire1Δ mutants restored Ftr1 localization and rescued the growth defects of the mutants. Both ire1Δ and hac1Δ mutants were avirulent in a mouse model of systemic candidiasis, indicating that an appropriate response to endoplasmic reticulum stress is important for the virulence of C. albicans. However, the specific requirement of Ire1 for the functionality of the high-affinity iron permease Ftr1, a well-established virulence factor, even in the absence of endoplasmic reticulum stress uncovers a novel Hac1-independent essential role of Ire1 in iron acquisition and virulence of C. albicans. KW - protein kinase KW - Ire1 KW - Candida albicans Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-300225 VL - 18 IS - 2 ER - TY - THES A1 - Reuter-Weissenberger, Philipp T1 - The role of a fungal-specific transcription regulator on vacuolar biology and host interaction in \(Candida\) \(albicans\) T1 - Die Rolle eines pilzspezifischen Transkriptionsfaktors für die Vakuole und Wirtsinteraktion von \(Candida\) \(albicans\) N2 - Microorganisms that colonize the human body face large fluctuations in their surroundings. Therefore, those microbes developed sophisticated mechanisms that allow them to adapt their cell biology and maintain cellular homeostasis. One organelle vital to preserve cell physiology is the vacuole. The vacuole exhibits a wide range of functions and is able to adjust itself in response to both external and internal stimuli. Moreover, it plays an important role in host interaction and virulence in fungi such as Candida albicans. Despite this connection, only a few regulatory proteins have been described to modulate vacuolar biology in fungal pathogens. Furthermore, whether such regulation alters fungus-host interplay remains largely unknown. This thesis focuses on the characterization of ZCF8, a fungus-specific transcription regulator in the human-associated yeast C. albicans. To this end, I combined genome-wide protein-DNA interaction assays and gene expression analysis that identified genes regulated by Zcf8p. Fluorescence microscopy uncovered that several top targets of Zcf8p localize to the fungal vacuole. Moreover, deletion and overexpression of ZCF8 resulted in alterations in vacuolar morphology and in luminal pH and rendered the fungus resistant or susceptible to a vacuole-disturbing drug. Finally, in vitro adherence assays showed that Zcf8p modulates the attachment of C. albicans to human epithelial cells in a vacuole-dependent manner. Given those findings, I posit that the previously uncharacterized transcription regulator Zcf8p modulates fungal attachment to epithelial cells in a manner that depends on the status of the fungal vacuole. Furthermore, the results highlight that vacuolar physiology is a substantial factor influencing the physical interaction between Candida cells and mammalian mucosal surfaces. N2 - Mikroorganismen, die den Menschen besiedeln, sind großen Schwankungen in ihrer Umgebung ausgesetzt. Daher haben sie ausgeklügelte Mechanismen entwickelt, die es ihnen ermöglichen, ihre Zellbiologie anzupassen und die zelluläre Homöostase aufrechtzuerhalten. Eine für die Aufrechterhaltung der Zellphysiologie wichtige Organelle ist die Vakuole. Sie verfügt über ein breites Spektrum an Funktionen und ist in der Lage, auf externe und interne Stimuli zu reagieren. Außerdem spielt dieses Organell eine wichtige Rolle bei der Pilz-Wirt-Interaktion und somit für die Pathogenität von Pilzen wie Candida albicans. Trotz dieses Zusammenhangs wurden bisher nur wenige regulatorische Proteine beschrieben, welche die Biologie der Vakuolen in pathogenen Pilzen modulieren. Zudem ist weitgehend unbekannt, ob eine solche Regulierung das Zusammenspiel von Pilz und Wirt verändert. Diese Arbeit konzentriert sich auf die Charakterisierung von ZCF8, einem pilzspezifischen Transkriptionsregulator in der pathogenen Hefe C. albicans. Zu diesem Zweck wurden Protein-DNA-Interaktionstests und Genexpressionsanalysen kombiniert, um Gene zu identifizieren, die direkt von Zcf8p reguliert werden. Fluoreszenzmikroskopie zeigte zudem, dass mehrere der wichtigsten Ziele von Zcf8p in der Pilzvakuole lokalisiert sind. Darüber hinaus führte die Deletion und Überexpression von ZCF8 zu Veränderungen der Morphologie und des luminalen pH-Werts der Vakuole, und veränderte die Sensitivität des Pilzes gegenüber Stoffen, welche Funktionen der Vakuole beeinträchtigen. Schließlich deuteten In-vitro-Adhärenztests daraufhin, dass Zcf8p die Anheftung von C. albicans an menschliche Epithelzellen auf eine Weise moduliert, die abhängig von der Vakuole ist. Angesichts dieser Ergebnisse kann davon ausgegangen werden, dass der bisher unbekannte Transkriptionsregulator ZCF8 die Interaktion zwischen Pilz- und Epithelzellen des Wirts kontrolliert, und das auf eine Weise, die von der Pilzvakuole abhängig ist. Des Weiteren, unterstreichen die Ergebnisse, dass die Physiologie der Vakuole ein wesentlicher Faktor ist, welcher die Interaktion zwischen C. albicans und dem Wirt beeinflusst. KW - Vakuole KW - Transkriptionsfaktor KW - Candida albicans KW - vacuole KW - host colonization KW - Candida albicans KW - transcription regulator Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-259287 ER - TY - JOUR A1 - Raschig, Martina A1 - Ramírez‐Zavala, Bernardo A1 - Wiest, Johannes A1 - Saedtler, Marco A1 - Gutmann, Marcus A1 - Holzgrabe, Ulrike A1 - Morschhäuser, Joachim A1 - Meinel, Lorenz T1 - Azobenzene derivatives with activity against drug‐resistant Candida albicans and Candida auris JF - Archiv der Pharmazie N2 - Increasing resistance against antimycotic drugs challenges anti‐infective therapies today and contributes to the mortality of infections by drug‐resistant Candida species and strains. Therefore, novel antifungal agents are needed. A promising approach in developing new drugs is using naturally occurring molecules as lead structures. In this work, 4,4'‐dihydroxyazobenzene, a compound structurally related to antifungal stilbene derivatives and present in Agaricus xanthodermus (yellow stainer), served as a starting point for the synthesis of five azobenzene derivatives. These compounds prevented the growth of both fluconazole‐susceptible and fluconazole‐resistant Candida albicans and Candida auris strains. Further in vivo studies are required to confirm the potential therapeutic value of these compounds. KW - antifungal drug KW - azobenzenes KW - Candida auris KW - Candida albicans Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-312295 VL - 356 IS - 2 ER - TY - JOUR A1 - Ramírez-Zavala, Bernardo A1 - Krüger, Ines A1 - Wollner, Andreas A1 - Schwanfelder, Sonja A1 - Morschhäuser, Joachim T1 - The Ypk1 protein kinase signaling pathway is rewired and not essential for viability in \(Candida\) \(albicans\) JF - PLoS Genetics N2 - Abstract Protein kinases are central components of almost all signaling pathways that control cellular activities. In the model organism Saccharomyces cerevisiae, the paralogous protein kinases Ypk1 and Ypk2, which control membrane lipid homeostasis, are essential for viability, and previous studies strongly indicated that this is also the case for their single ortholog Ypk1 in the pathogenic yeast Candida albicans. Here, using FLP-mediated inducible gene deletion, we reveal that C. albicans ypk1Δ mutants are viable but slow-growing, explaining prior failures to obtain null mutants. Phenotypic analyses of the mutants showed that the functions of Ypk1 in regulating sphingolipid biosynthesis and cell membrane lipid asymmetry are conserved, but the consequences of YPK1 deletion are milder than in S. cerevisiae. Mutational studies demonstrated that the highly conserved PDK1 phosphorylation site T548 in its activation loop is essential for Ypk1 function, whereas the TORC2 phosphorylation sites S687 and T705 at the C-terminus are important for Ypk1-dependent resistance to membrane stress. Unexpectedly, Pkh1, the single C. albicans orthologue of Pkh1/Pkh2, which mediate Ypk1 phosphorylation at the PDK1 site in S. cerevisiae, was not required for normal growth of C. albicans under nonstressed conditions, and Ypk1 phosphorylation at T548 was only slightly reduced in pkh1Δ mutants. We found that another protein kinase, Pkh3, whose ortholog in S. cerevisiae cannot substitute Pkh1/2, acts redundantly with Pkh1 to activate Ypk1 in C. albicans. No phenotypic effects were observed in cells lacking Pkh3 alone, but pkh1Δ pkh3Δ double mutants had a severe growth defect and Ypk1 phosphorylation at T548 was completely abolished. These results establish that Ypk1 is not essential for viability in C. albicans and that, despite its generally conserved function, the Ypk1 signaling pathway is rewired in this pathogenic yeast and includes a novel upstream kinase to activate Ypk1 by phosphorylation at the PDK1 site. Author summary Protein kinases are key components of cellular signaling pathways, and elucidating the specific roles of individual kinases is important to understand how organisms adapt to changes in their environment. The protein kinase Ypk1 is highly conserved in eukaryotic organisms and crucial for the maintenance of cell membrane homeostasis. It was previously thought that Ypk1 is essential for viability in the pathogenic yeast Candida albicans, as in the model organism Saccharomyces cerevisiae. Here, by using forced, inducible gene deletion, we reveal that C. albicans mutants lacking Ypk1 are viable but have a strong growth defect. The phenotypes of the mutants indicate that the known functions of Ypk1 are conserved in C. albicans, but loss of this kinase has less severe consequences than in S. cerevisiae. We also unravel the puzzling previous observation that C. albicans mutants lacking the Ypk1-activating kinase Pkh1, which is essential in S. cerevisiae, have no obvious growth defects. We show that the protein kinase Pkh3, which has not previously been implicated in the Ypk1 signaling pathway, can substitute Pkh1 and activate Ypk1 in C. albicans. These findings provide novel insights into this conserved signaling pathway and how it is rewired in a human-pathogenic fungus. KW - Ypk1 KW - protein kinase KW - signaling pathway KW - Candida albicans Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-350076 VL - 19 IS - 8 ER - TY - JOUR A1 - Ramírez-Zavala, Bernardo A1 - Betsova, Darina A1 - Schwanfelder, Sonja A1 - Krüger, Ines A1 - Mottola, Austin A1 - Krüger, Thomas A1 - Kniemeyer, Olaf A1 - Brakhage, Axel A. A1 - Morschhäuser, Joachim T1 - Multiple phosphorylation sites regulate the activity of the repressor Mig1 in \(Candida\) \(albicans\) JF - mSphere N2 - ABSTRACT The highly conserved heterotrimeric protein kinase SNF1 is important for metabolic adaptations in the pathogenic yeast Candida albicans. A key function of SNF1 is to inactivate the repressor protein Mig1 and thereby allow the expression of genes that are required for the utilization of alternative carbon sources when the preferred carbon source, glucose, is absent or becomes limiting. However, how SNF1 controls Mig1 activity in C. albicans has remained elusive. Using a phosphoproteomics approach, we found that Mig1 is phosphorylated at multiple serine residues. Replacement of these serine residues by nonphosphorylatable alanine residues strongly increased the repressor activity of Mig1 in cells lacking a functional SNF1 complex, indicating that additional protein kinases are involved in the regulation of Mig1. Unlike wild-type Mig1, whose levels strongly decreased when the cells were grown on sucrose or glycerol instead of glucose, the levels of a mutant Mig1 protein lacking nine phosphorylation sites remained high under these conditions. Despite the increased protein levels and the absence of multiple phosphorylation sites, cells with a functional SNF1 complex could still sufficiently inhibit the hyperactive Mig1 to enable wild-type growth on alternative carbon sources. In line with this, phosphorylated forms of the mutant Mig1 were still detected in the presence and absence of a functional SNF1, demonstrating that Mig1 contains additional, unidentified phosphorylation sites and that downstream protein kinases are involved in the control of Mig1 activity by SNF1. IMPORTANCE The SNF1 protein kinase signaling pathway, which is highly conserved in eukaryotic cells, is important for metabolic adaptations in the pathogenic yeast Candida albicans. However, so far, it has remained elusive how SNF1 controls the activity of one of its main effectors, the repressor protein Mig1 that inhibits the expression of genes required for the utilization of alternative carbon sources when glucose is available. In this study, we have identified multiple phosphorylation sites in Mig1 that contribute to its inactivation. Mutation of these sites strongly increased Mig1 repressor activity in the absence of SNF1, but SNF1 could still sufficiently inhibit the hyperactive Mig1 to enable growth on alternative carbon sources. These findings reveal features of Mig1 that are important for controlling its repressor activity. Furthermore, they demonstrate that both SNF1 and additional protein kinases regulate Mig1 in this pathogenic yeast. KW - Candida albicans KW - SNF1 KW - Mig1 KW - protein kinase KW - signaling pathway Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-350060 VL - 8 IS - 6 ER -